These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 10329040)
1. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Kanazawa K; Suzuki T; Tokashiki M Gynecol Oncol; 1999 May; 73(2):237-41. PubMed ID: 10329040 [TBL] [Abstract][Full Text] [Related]
2. Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Cliby WA; Aletti GD; Wilson TO; Podratz KC Gynecol Oncol; 2006 Dec; 103(3):797-801. PubMed ID: 17052746 [TBL] [Abstract][Full Text] [Related]
3. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes. Duraker N; Caynak ZC Cancer; 2005 Aug; 104(4):700-7. PubMed ID: 16003773 [TBL] [Abstract][Full Text] [Related]
5. Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. Tang R; Wang JY; Chen JS; Chang-Chien CR; Tang S; Lin SE; You YT; Hsu KC; Ho YS; Fan HA J Am Coll Surg; 1995 Jun; 180(6):705-12. PubMed ID: 7773484 [TBL] [Abstract][Full Text] [Related]
6. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer. Yavuzcan A; Baloglu A; Cetinkaya B Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011 [TBL] [Abstract][Full Text] [Related]
7. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373 [TBL] [Abstract][Full Text] [Related]
8. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. McMeekin DS; Lashbrook D; Gold M; Scribner DR; Kamelle S; Tillmanns TD; Mannel R Gynecol Oncol; 2001 Aug; 82(2):375-9. PubMed ID: 11531298 [TBL] [Abstract][Full Text] [Related]
9. Significance of lymph node sampling in epithelial carcinoma of the ovary. Carnino F; Fuda G; Ciccone G; Iskra L; Guercio E; Dadone D; Conte PF Gynecol Oncol; 1997 Jun; 65(3):467-72. PubMed ID: 9190977 [TBL] [Abstract][Full Text] [Related]
10. The validity and significance of substages of advanced ovarian cancer. Partridge EE; Gunter BC; Gelder MS; Alvarez RD; Soong SJ; Austin JM; Kilgore LC Gynecol Oncol; 1993 Feb; 48(2):236-41. PubMed ID: 8428697 [TBL] [Abstract][Full Text] [Related]
11. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer. Eisenkop SM; Spirtos NM Gynecol Oncol; 2001 Jul; 82(1):143-9. PubMed ID: 11426976 [TBL] [Abstract][Full Text] [Related]
12. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Aletti GD; Dowdy S; Podratz KC; Cliby WA Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488 [TBL] [Abstract][Full Text] [Related]
13. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis. Greene FL; Stewart AK; Norton HJ J Clin Oncol; 2004 May; 22(10):1778-84. PubMed ID: 14769855 [TBL] [Abstract][Full Text] [Related]
14. Analysis of FIGO Stage IIIc endometrial cancer patients. McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962 [TBL] [Abstract][Full Text] [Related]
15. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases. Djordjevic B; Malpica A Am J Surg Pathol; 2010 Jan; 34(1):1-9. PubMed ID: 19898226 [TBL] [Abstract][Full Text] [Related]
16. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution. Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951 [TBL] [Abstract][Full Text] [Related]
17. Is there any prognostically different subgroup among patients with stage IIIC (any TN3M0) breast carcinoma? Duraker N; Caynak ZC; Bati B Ann Surg Oncol; 2008 Feb; 15(2):430-7. PubMed ID: 17912589 [TBL] [Abstract][Full Text] [Related]
19. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study. Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725 [TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]